Dimitra Skondra to Metformin
This is a "connection" page, showing publications Dimitra Skondra has written about Metformin.
Connection Strength
6.304
-
The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy. Invest Ophthalmol Vis Sci. 2024 Mar 05; 65(3):23.
Score: 0.847
-
INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES. Retina. 2024 Feb 01; 44(2):197-204.
Score: 0.841
-
ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT. Retina. 2024 Feb 01; 44(2):205-213.
Score: 0.841
-
Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes. JAMA Ophthalmol. 2024 Jan 01; 142(1):53-57.
Score: 0.836
-
Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study. Invest Ophthalmol Vis Sci. 2023 08 01; 64(11):22.
Score: 0.812
-
Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature. Exp Biol Med (Maywood). 2022 02; 247(4):317-329.
Score: 0.731
-
Methodological Considerations for the Case-Control Study of Metformin and Age-Related Macular Degeneration-Reply. JAMA Ophthalmol. 2021 08 01; 139(8):919-920.
Score: 0.707
-
Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study. JAMA Ophthalmol. 2021 03 01; 139(3):302-309.
Score: 0.687